There are multiple reasons for Orphan drug designation.
The rare disease criteria is one option. As far as I am aware there has always been another path which is for a serious condition that has no other recognised treatment.
Below from tga listing of orphan drug. This is Australian tga but I believe usa fda has similar. The treatment this guy received could fit if it was truly as life threatening as the announcement indicated, although it was probably more about quality of life than life threatening.
2. Serious Condition the indication is the treatment,
prevention or diagnosis of a life-
threatening or seriously
debilitating condition1 in a
particular class of patients (the
relevant patient class)
the indication is the treatment,
prevention or diagnosis of a life-
threatening or seriously
debilitating condition
- Forums
- ASX - By Stock
- RCE
- RCE Charts
RCE Charts, page-946
-
- There are more pages in this discussion • 1,218 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
|
|||||
Last
47.0¢ |
Change
-0.025(5.05%) |
Mkt cap ! $108.8M |
Open | High | Low | Value | Volume |
49.8¢ | 49.8¢ | 46.5¢ | $19.89K | 42.26K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12500 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.5¢ | 210 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12500 | 0.465 |
3 | 62621 | 0.460 |
5 | 50769 | 0.455 |
5 | 25323 | 0.450 |
2 | 102272 | 0.440 |
Price($) | Vol. | No. |
---|---|---|
0.475 | 210 | 1 |
0.480 | 101 | 1 |
0.485 | 4500 | 1 |
0.495 | 4324 | 1 |
0.500 | 29949 | 2 |
Last trade - 10.47am 13/08/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online